Suicide risk in bipolar disorder: a brief review

P Dome, Z Rihmer, X Gonda - Medicina, 2019 - mdpi.com
Bipolar disorders (BDs) are prevalent mental health illnesses that affect about 1–5% of the
total population, have a chronic course and are associated with a markedly elevated …

[HTML][HTML] The antidepressant effect of ketamine is dampened by concomitant benzodiazepine medication

V Andrashko, T Novak, M Brunovsky, M Klirova… - Frontiers in …, 2020 - frontiersin.org
The rapid antidepressant effect of ketamine has become a breakthrough in the research and
treatment of depression. Although predictive and modulating factors of the response to …

[HTML][HTML] A potential case of acute ketamine withdrawal: clinical implications for the treatment of refractory depression

N Roxas, C Ahuja, J Isom… - American Journal of …, 2021 - Am Psychiatric Assoc
Mr. A, a 35-year-old military veteran with a history of posttraumatic stress disorder (PTSD),
bipolar II disorder, alcohol use disorder in full sustained remission, cannabis use disorder …

Ketamine plasmonic sensor using polyaniline-rGO-Fe3O4 nanocomposite thin layer

AR Sadrolhosseini, SM Hamidi, M Kazemzad… - Sensors and Actuators A …, 2022 - Elsevier
Ketamine is a narcotic and palliative substance and the measurement of the low
concentration of ketamine is a great intense interest matter in biotechnology and medicine …

Concerns on the Use of Ketamine in the Treatment of Depression

AK Barik, R Chauhan, A Reddy… - Indian Journal of …, 2024 - journals.sagepub.com
To the Editor, Major depressive disorder is the third leading cause of global disability and is
often associated with incomplete recovery, numerous relapses, and functional impairment …

Ketamine's pharmacogenomic network in human brain contains sub-networks associated with glutamate neurotransmission and with neuroplasticity

GA Higgins, SA Handelman, A Allyn-Feuer, AS Ade… - bioRxiv, 2020 - biorxiv.org
The pharmacogenomic network responsible for the rapid antidepressant action of ketamine
and concomitant adverse events in patients has been poorly defined. Integrative, multi-scale …

[HTML][HTML] Efficacy of Ketamine Therapy in the Treatment of Refractory Major Depressive Disorder

H van Oers - Journal of Exploratory Research in Pharmacology, 2023 - xiahepublishing.com
Major depressive disorder (MDD) is a prevalent and highly debilitating illness that causes
significant functional impairment in many patients. Conventional pharmacotherapy, such as …

Efeitos do Uso Concomitante de Benzodiazepinas e Antidepressivos na perceção da Intencionalidade dos Atos

MS de Paiva - 2023 - search.proquest.com
Embora o consumo concomitante de benzodiazepinas e antidepressivos represente um
risco futuro para a função executiva, os seus efeitos na cognição social são ainda …

Blood Pressure Changes During Ketamine Infusion for the Treatment of Depression

M Ansari, B Pittman, D Tylee, R Ostroff… - Available at SSRN … - papers.ssrn.com
Objective: In this study, we aimed to examine blood pressure changes during ketamine
infusion for depression, and exploring the factors associated with these changes. Method …

Emerging Therapies in Psychiatry

IA Cook - Focus, 2018 - Am Psychiatric Assoc
Despite the retreat of many large pharmaceutical companies from research and
development in the “CNS space,” recent years have seen the development of an array of …